Buchumschlag

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients

High concentrations of HDL cholesterol are considered to indicate efficient reverse cholesterol transport and to protect from atherosclerosis. However, HDL has been suggested to be dysfunctional in ESRD. Hence, our main objective was to investigate the effect of HDL cholesterol on outcomes in mainte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Silbernagel, Günther (VerfasserIn) , Genser, Bernd (VerfasserIn) , Grammer, Tanja B. (VerfasserIn) , Ritz, Eberhard (VerfasserIn) , März, Winfried (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2015
In: Journal of the American Society of Nephrology
Year: 2015, Jahrgang: 26, Heft: 2, Pages: 484-492
ISSN:1533-3450
DOI:10.1681/ASN.2013080816
Online-Zugang:Verlag, teilw. kostenfrei, Volltext: http://dx.doi.org/10.1681/ASN.2013080816
Verlag, teilw. kostenfrei, Volltext: http://jasn.asnjournals.org.ezproxy.medma.uni-heidelberg.de/content/26/2/484
Volltext
Verfasserangaben:Günther Silbernagel, Bernd Genser, Christiane Drechsler, Hubert Scharnagl, Tanja B. Grammer, Tatjana Stojakovic, Vera Krane, Eberhard Ritz, Christoph Wanner, and Winfried März

MARC

LEADER 00000caa a2200000 c 4500
001 1562971433
003 DE-627
005 20241209145816.0
007 cr uuu---uuuuu
008 170901s2015 xx |||||o 00| ||eng c
024 7 |a 10.1681/ASN.2013080816  |2 doi 
035 |a (DE-627)1562971433 
035 |a (DE-576)492971439 
035 |a (DE-599)BSZ492971439 
035 |a (OCoLC)1340978781 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Silbernagel, Günther  |e VerfasserIn  |0 (DE-588)1069585556  |0 (DE-627)822063751  |0 (DE-576)42929235X  |4 aut 
245 1 0 |a HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients  |c Günther Silbernagel, Bernd Genser, Christiane Drechsler, Hubert Scharnagl, Tanja B. Grammer, Tatjana Stojakovic, Vera Krane, Eberhard Ritz, Christoph Wanner, and Winfried März 
264 1 |c 2015 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 10. Juli 2014 
500 |a Gesehen am 01.09.2017 
520 |a High concentrations of HDL cholesterol are considered to indicate efficient reverse cholesterol transport and to protect from atherosclerosis. However, HDL has been suggested to be dysfunctional in ESRD. Hence, our main objective was to investigate the effect of HDL cholesterol on outcomes in maintenance hemodialysis patients with diabetes. Moreover, we investigated the associations between the major protein components of HDL (apoA1, apoA2, and apoC3) and end points. We performed an exploratory, post hoc analysis with 1255 participants (677 men and 578 women) of the German Diabetes Dialysis study. The mean age was 66.3 years and the mean body mass index was 28.0 kg/m2. The primary end point was a composite of cardiac death, myocardial infarction, and stroke. The secondary end point included all-cause mortality. The mean duration of follow-up was 3.9 years. A total of 31.3% of the study participants reached the primary end point and 49.1% died from any cause. HDL cholesterol and apoA1 and apoC3 quartiles were not related to end points. However, there was a trend toward an inverse association between apoA2 and all-cause mortality. The hazard ratio for death from any cause in the fourth quartile compared with the first quartile of apoA2 was 0.63 (95% confidence interval, 0.40 to 0.89). The lack of an association between HDL cholesterol and cardiovascular risk may support the concept of dysfunctional HDL in hemodialysis. The possible beneficial effect of apoA2 on survival requires confirmation in future studies. 
650 4 |a cardiovascular disease 
650 4 |a chronic dialysis 
650 4 |a lipids 
650 4 |a mortality risk 
700 1 |a Genser, Bernd  |e VerfasserIn  |0 (DE-588)1030401292  |0 (DE-627)735219028  |0 (DE-576)378224581  |4 aut 
700 1 |a Grammer, Tanja B.  |d 1972-  |e VerfasserIn  |0 (DE-588)1030134952  |0 (DE-627)734830041  |0 (DE-576)377941018  |4 aut 
700 1 |a Ritz, Eberhard  |d 1938-2023  |e VerfasserIn  |0 (DE-588)106673386  |0 (DE-627)610528866  |0 (DE-576)311552501  |4 aut 
700 1 |a März, Winfried  |d 1958-  |e VerfasserIn  |0 (DE-588)1027603599  |0 (DE-627)729463605  |0 (DE-576)373454635  |4 aut 
773 0 8 |i Enthalten in  |a American Society of Nephrology  |t Journal of the American Society of Nephrology  |d Washington, DC : American Society of Nephrology, 1990  |g 26(2015), 2, Seite 484-492  |h Online-Ressource  |w (DE-627)324616481  |w (DE-600)2029124-3  |w (DE-576)094113769  |x 1533-3450  |7 nnas 
773 1 8 |g volume:26  |g year:2015  |g number:2  |g pages:484-492  |g extent:9  |a HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients 
856 4 0 |u http://dx.doi.org/10.1681/ASN.2013080816  |x Verlag  |x Resolving-System  |z teilw. kostenfrei  |3 Volltext 
856 4 0 |u http://jasn.asnjournals.org.ezproxy.medma.uni-heidelberg.de/content/26/2/484  |x Verlag  |z teilw. kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20170901 
993 |a Article 
994 |a 2015 
998 |g 1027603599  |a März, Winfried  |m 1027603599:März, Winfried  |d 60000  |d 61400  |e 60000PM1027603599  |e 61400PM1027603599  |k 0/60000/  |k 1/60000/61400/  |p 10  |y j 
998 |g 106673386  |a Ritz, Eberhard  |m 106673386:Ritz, Eberhard  |d 910000  |d 910100  |e 910000PR106673386  |e 910100PR106673386  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1030134952  |a Grammer, Tanja B.  |m 1030134952:Grammer, Tanja B.  |d 60000  |d 65300  |e 60000PG1030134952  |e 65300PG1030134952  |k 0/60000/  |k 1/60000/65300/  |p 5 
998 |g 1030401292  |a Genser, Bernd  |m 1030401292:Genser, Bernd  |d 60000  |d 65300  |e 60000PG1030401292  |e 65300PG1030401292  |k 0/60000/  |k 1/60000/65300/  |p 2 
999 |a KXP-PPN1562971433  |e 2979134902 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1681/ASN.2013080816"],"eki":["1562971433"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"id":{"eki":["324616481"],"issn":["1533-3450"],"zdb":["2029124-3"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1990 -"],"part":{"text":"26(2015), 2, Seite 484-492","pages":"484-492","issue":"2","extent":"9","year":"2015","volume":"26"},"origin":[{"dateIssuedKey":"1990","publisherPlace":"Washington, DC ; [Erscheinungsort nicht ermittelbar]","publisher":"American Society of Nephrology ; Ovid","dateIssuedDisp":"1990-"}],"recId":"324616481","titleAlt":[{"title":"JASN"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of the American Society of Nephrology","subtitle":"JASN","title_sort":"Journal of the American Society of Nephrology"}],"language":["eng"],"corporate":[{"display":"American Society of Nephrology","role":"aut"}],"disp":"American Society of NephrologyJournal of the American Society of Nephrology","note":["Gesehen am 19.08.24"]}],"title":[{"title":"HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients","title_sort":"HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients"}],"language":["eng"],"person":[{"role":"aut","display":"Silbernagel, Günther","given":"Günther","family":"Silbernagel"},{"given":"Bernd","family":"Genser","role":"aut","display":"Genser, Bernd"},{"family":"Grammer","given":"Tanja B.","display":"Grammer, Tanja B.","role":"aut"},{"role":"aut","display":"Ritz, Eberhard","given":"Eberhard","family":"Ritz"},{"given":"Winfried","family":"März","role":"aut","display":"März, Winfried"}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"recId":"1562971433","name":{"displayForm":["Günther Silbernagel, Bernd Genser, Christiane Drechsler, Hubert Scharnagl, Tanja B. Grammer, Tatjana Stojakovic, Vera Krane, Eberhard Ritz, Christoph Wanner, and Winfried März"]},"note":["Online veröffentlicht: 10. Juli 2014","Gesehen am 01.09.2017"]} 
SRT |a SILBERNAGEHDLCHOLEST2015 

Ähnliche Einträge